HEMOGENYX
HemoGenyx LLC, a privately held biopharmaceutical company, is developing a revolutionary new treatment for blood diseases, such as leukemia and lymphoma. They leverage a special class of cells, which can generate cancer-free blood stem cells. Their therapy will dramatically increase the efficacy of bone marrow transplants and eliminate the need for donors.
HEMOGENYX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.hemogenyx.com
Total Employee:
11+
Status:
Active
Contact:
+1 (347) 735-8380
Email Addresses:
[email protected]
Total Funding:
61.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Mint Capital
Mint Capital investment in Post-IPO Debt - HemoGenyx
43North
43North investment in Seed Round - HemoGenyx
Official Site Inspections
http://www.hemogenyx.com
- Host name: li677-21.members.linode.com
- IP address: 88.80.184.21
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "HemoGenyx"
About – Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom. LEI …See details»
Hemogenyx Pharmaceuticals – Breakthrough therapies for the …
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your …See details»
Company Information – Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom. LEI …See details»
HemoGenyx - Crunchbase Company Profile & Funding
HemoGenyx LLC, a privately held biopharmaceutical company, is developing a revolutionary new treatment for blood diseases, such as leukemia and …See details»
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment …
Prevail Partners, LLC to invest again in Hemogenyx Pharmaceuticals Prevail InfoWorks, Inc. to act as Clinical Research Organization (CRO) for upcoming Phase I pediatric clinical study …See details»
Hemogenyx Pharmaceuticals PLC Announces Final Results
Apr 25, 2024 LONDON, UK / ACCESSWIRE / April 25, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood …See details»
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Jun 17, 2024 Operations Update. LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical …See details»
Hemogenyx Pharmaceuticals explains share consolidation, …
5 days ago Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO Dr Vladislav Sandler and non-executive director Peter Redmond talked with Proactive's Stephen Gunnion …See details»
Hemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T …
Nov 18, 2022 Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals …See details»
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment …
Oct 2, 2024 Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals …See details»
Hemogenyx Pharmaceuticals PLC Announces FDA …
Hemogenyx Pharmaceuticals is a publicly traded company (LSE:HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York ...See details»
Hemogenyx Pharmaceuticals Announces Strategic Investment …
Sep 18, 2023 The Company’s wholly owned subsidiary, Hemogenyx Pharmaceuticals LLC, has also signed a Master Service and Technology Agreement (“MSTA”) with Prevail InfoWorks, …See details»
Mission, Vision & Core Values of HemoGenyx – CBM
Oct 2, 2024 HemoGenyx is a biotechnology company with a bold mission to revolutionize the field of stem cell therapy and regenerative medicine. Our vision is to provide innovative …See details»
Hemogenyx Pharmaceuticals PLC Announces Final Results - Yahoo …
Apr 25, 2024 Final Results. LONDON, UK / ACCESSWIRE / April 25, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and …See details»
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment …
Oct 2, 2024 Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, announces tha tPrevail Partners, LLC, an …See details»
Technology – Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom. LEI …See details»
HEMO Stock Price Quote | Morningstar
Oct 25, 2024 Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC. Accesswire Oct 2, 2024 10:45am. Hemogenyx Pharmaceuticals PLC …See details»
Hemogenyx Pharmaceuticals PLC Announces CBR Expanded to …
Nov 27, 2023 Chimeric Bait Receptor-programmed macrophages show promise for treatment of Non-Hodgkin LymphomaLONDON, UK / ACCESSWIRE / November 27, 2023 / Hemogenyx …See details»
News – Hemogenyx Pharmaceuticals
Oct 2, 2024 Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom. …See details»